Select Medical Holdings Corp

Select Medical Holdings Corp(SEM)股票分析

$16.510

-0.020 (-0.12%)收盘时

Loading chart…
最高
16.560
开盘
16.530
成交量加权均价
16.53
成交量
27.84M
市值
4.56B
最低
16.510
成交额
460.09M
企业价值/息税折旧摊销前利润(TTM)
9.06

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.

AI 分析 of Select Medical Holdings Corp (SEM)

持有

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

分析师评级(6)

上行空间 +13.57%
买入
4 买入
0 持有
2 卖出
当前: 16.51
最低
17.00
平均
18.75
最高
21.00

Mizuho

2026-05-12

目标价

$17

中性

RBC Capital

2026-02-23

目标价

$19

跑赢大盘

BofA

2025-11-25

目标价

—

No Rating

BofA

2025-09-10

目标价

$15

买入

UBS

2025-08-04

目标价

$14

中性

估值指标

Select Medical Holdings Corp(SEM)当前预期市盈率为 13.42,5 年平均预期市盈率为 13.78。

预期市盈率

合理
5 年均值 P/E
13.78
当前P/E
13.42
高估
16.29
低估
11.27

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
10.31
当前EV/EBITDA
9.06
高估
11.33
低估
9.30

预期市销率

低估
5 年均值 P/S
0.47
当前P/S
0.34
高估
0.58
低估
0.36

Alphio AI 对 SEM 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%SEM

$15.70

情景价格

基

基准

基准 · 50%SEM

$13.55

情景价格

悲

悲观

悲观 · 25%SEM

$11.91

情景价格

持有 SEM 的大户

E

Eversept Partners, L.P.

+ 持有SEM

-8.08%

3个月收益率

事件时间线

2026-06-30 (ET)

16:30:00

Select Medical Completes Acquisition, Ceases Trading

2026-06-26 (ET)

17:30:00

Select Medical Holdings to be Acquired

2026-05-21 (ET)

09:10:00

Select Medical and Carilion Clinic Partner to Build 50-Bed Rehab Hospital

2026-04-30 (ET)

16:50:00

Sees FY25 Adjusted EBITDA at $520M-$540M

16:40:00

Company Reports Q1 Revenue of $1.421B

资讯

SEM 常见问题 —— 由 Alphio AI 解答

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

6 analysts cover SEM: 4 rate it Buy, 0 Hold and 2 Sell. The average price target is 18.75.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易